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Abstract
Burn damage can lead to a state of immune dysregulation that facilitates the development of
infections in patients. The most deleterious impact of this dysfunction is the loss of the skin’s
natural protective barrier. Furthermore, the risk of infection is exacerbated by protracted hospi-
talization, urinary catheters, endotracheal intubation, inhalation injury, arterial lines and central
venous access, among other mainstays of burn care. Currently, infections comprise the leading
cause of mortality after major burn injuries, which highlights the improvements observed over
the last 50 years in the care provided to burn victims. The need to implement the empirical
selection of antibiotic therapy to treat multidrug-resistant bacteria may concomitantly lead to an
overall pervasiveness of difficult-to-treat pathogens in burn centres, as well as the propagation of
antimicrobial resistance and the ultimate dysregulation of a healthy microbiome. While preliminary
studies are examining the variability and evolution of human and mice microbiota, both during the
early and late phase burn injury, one must consider that abnormal microbiome conditions could
influence the systemic inflammatory response. A better understanding of the changes in the post-
burn microbiome might be useful to interpret the provenance and subsequent development of
infections, as well as to come up with inferences on the prognosis of burn patients. This review
aims to summarise the current findings describing the microbiological changes in different organs
and systems of burn patients and how these alterations affect the risks of infections, complications,
and, ultimately, healing.
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Background
Burn injuries are a frequent source of morbidity and mor-
tality worldwide. For example, in the USA alone, around
half a million people have burn injuries [1]. As a matter of
fact, 40 000 injured subjects are referred to an emergency
department every year [1]. Moreover, as many as 75% of
these patients are admitted to a specialized burn unit [1,2]
and three-fourths of the deaths recorded are associated with
sepsis and complications from infections in severely burned
victims [2].
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As an instant systemic inflammatory response spreads
throughout the body, other organs may also be affected [3].
In addition to the skin, inflammation in the lungs, liver
and intestines can also be observed after burn damage [4].
Notably, in the gastrointestinal tract, burn injuries cause
mesenteric vasoconstriction and produce a hypoxic environ-
ment, as shown in previous publications [3, 4]. Therefore,
the reperfusion of blood to these tissues leads to a profound
variation in oxygen levels, resulting in cellular stress, necrosis
and, ultimately, a breakdown of the epithelial barrier. The
latter is characterized by an increase in intestinal permeability
and the displacement of the bacteria to the mesenteric lymph
nodes [3, 4].
The risk of infection for burn patients is aggravated by
additional factors such as protracted hospitalization, urinary
catheters, endotracheal intubation, inhalation injury, arterial
lines and central venous access [2]. Additionally, the compo-
sition and biodiversity of the microbiome can be affected by
diet, environment, medication, infection, inflammation and,
eventually, burn injuries as well [5–8] (Figure 1). On the first
day after a severe burn, Gram-negative aerobic bacteria can
fill up the gastrointestinal tract [5], leading to physiological
conditions that enable opportunistic pathogens to overgrow
and invade the host. Therefore, it is paramount to understand
that the disequilibrium of the microbiome occurs only after a
complication, such as an injury, and that commensal bacteria
can play a crucial role in bacterial translocation, barrier
dysfunction and sepsis. We aim to summarise the current data
collected on alterations in the gut, skin and lungs, those being
the most studied compartments, and how such changes can
lead to the development of infections and complications while
also contributing information that would aid in the healing of
burn victims.
Epidemiology and risk factors for infections
in burn patients
The timeline of hospital-associated infections in patients with
burn injuries is completely predictable. It is frequent for skin
and soft tissue infections to arise during the first week of
hospitalization. Meanwhile, pneumonia, bloodstream infec-
tions and urinary tract infections tend to appear later. Accord-
ingly, there is a clear preponderance of Gram-positive rods
over Gram-negative bacteria at the early onset of infection.
Nonetheless, the exact opposite can be observed later [2],
which correlates with the median onset of infection, that is,
30 days after admission [9]. Therefore, the length of hospital-
ization is proportional to the type of bacteria isolated from
the burn patient, as shown in several studies. A retrospective
study conducted in a Canadian burn centre involving 125
admitted burn victims showed that Pseudomonas aeruginosa
(P. aeruginosa) was rarely present within the first week of hos-
pital admission [10]. However, the presence of P. aeruginosa
increased to 55% of patients assessed 28 days after admission.
The opposite could be observed for Haemophilus influen-
zae. On average, it was isolated from 36% of the patients
during the first week, yet it declined to virtually zero in the
following 7 days [10]. A similar increase in P. aeruginosa was
identified in a study of 5524 burn patients from 2004 to 2013.
The latter demonstrated that Gram-positive organisms tend
to appear earlier when compared with Gram-negative ones
[9]. Although the time of hospitalization is related to several
clinical characteristics, such as burn extent and presence of
inhalational injury, hospital length of stay is one of the signif-
icant risk factors for infection by multidrug-resistant (MDR)
bacteria in burn victims. Infection-attributable mortality in
burn patients ranges from 50 to 75% [11, 12] and infections
caused by MDR bacteria increase mortality from 42 to 86%
in patients with burn-related sepsis [2, 13–15].
Likewise, the risk factors for the acquisition of MDR that
are usually associated with other patient populations, such
as the use of urinary catheters, endotracheal tubes and other
invasive medical instruments, as well as past antibiotic expo-
sure, have also been reported for the burn group. In the previ-
ously mentioned Canadian study involving 125 patients, 6%
had isolates that tested positive for MDR during the first week
of hospital admittance. That percentage grew to 44% after
28 days [10]. Additionally, in a study of 5000 patients with
burn injuries, the rate of infection by MDR Gram-negative
bacteria demonstrated a significant rise during their hospital
stay [9]. Data show that in the first 7 days after admission, the
rate of Enterobacteriaceae was 0.04 for carbapenem-resistant
Enterobacteriaceae (CPE), 0.26 for extended-spectrum β-
lactamase-producing Enterobacteriaceae (ESBL-E) and 0.52
for fluoroquinolone-resistant Enterobacteriaceae [9]. How-
ever, from the fourth week onwards, the rates increased to
0.82 for CPE, 0.46 for ESBL-E and 2.61 for fluoroquinolone-
resistant Enterobacteriaceae [9]. The specific rates for MDR
Pseudomonas spp. went up from 0.04 per 1000 patient-
days during the first 7 days of hospitalization to 1.85 per
1000 patient-days from week 4 onwards [9]. The spread
of antimicrobial resistance observed over the last decade
may be linked to the pervasive administration of broad-
spectrum antibiotics, which could endanger human health in
the future [16–20]. Simultaneously, the gastrointestinal tract
of the patients is colonized by resistant bacteria, taking over
the living microbiota, which is one of the main risk factors for
the development of infections caused by MDR bacteria such
as carbapenemase-producing Klebsiella pneumoniae (CP-Kp)
or Candida spp. [21, 22]. An efficient treatment strategy to
revert to healthy function might be the modulation of the gut
microbiota. Burn-injured subjects are a high-risk population
for infections and over-perscription of antimicrobial drugs [2,
16, 17]. The effects of antibiotics on the microbiome have
been increasingly reported and the prescription of antibiotics
is continuing to rise [15, 18–20]. Hence, additional investi-
gation on the specific effect of antibiotics and the results of
proliferation of MDR in the gut still needs to be conducted
[2, 15, 18–20]. Understanding the complex components of
the microbiome and its modification during burn trauma
is one of the research highlights in this field. Given this
epidemiological situation, the continuous increase of MDR
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Figure 1. Main changes in skin, lung and gut microbiome composition in burn patients. MDR multidrug-resistant
infections observed in recent years and the high infection-
related mortality, it is crucial to identify patients at high
risk for infections and support the creation of ‘antimicrobial
stewardship’ programmes in this setting [16, 17].
Review
Methods
A narrative review of the available literature was performed
using the PubMed database and the Cochrane library. The
search terms included ‘microbiome in burn patients’ and
‘microbiome in burn injury’. The Medical Subject Heading
(MeSH) terms were as follows: ‘microbiome’ [All Fields]
AND (‘burn patients’ [MeSH Terms] OR (‘burn injury’ [All
Fields] OR ‘burn’ [All Fields] AND ‘patients’ [All Fields])
OR ‘burn’ [All Fields]) AND (‘injury’). The defined search
period from 1 September 2000 to 1 May 2020 was selected
to compare studies from different periods given the changes
in the microbiome and burn knowledge. Given the nature
of the review, no ethics approval was required. The search
was performed by two investigators (SC and TL). A total
of 144 studies were identified (PubMed: 144, Cochrane:
0). Two investigators then reviewed the articles, initially by
title and abstract and then in detail, using a customized
data abstraction form. Studies were excluded if they had
incorrect subject matter, were duplications, or were case
reports, commentaries, editorials or reviews. Only studies
in English were included. A total of 24 studies were iden-
tified for full-text review as they contained original data
(Figure 2).
Gut microbiota in burns
Disruption of the intestinal barrier that leads to increased
intestinal permeability and translocation of bacteria [21 22]
or endotoxins are the frequent adverse events affecting gut
colonocytes after a severe burn injury [23]. The loss of
the structural integrity in the intestinal epithelial barrier
may cause sepsis and subsequent multiple organ dysfunction
syndromes, leading to a higher risk of mortality in burn
victims [24–26]. Nonetheless, most of the supposed under-
lying mechanisms behind gut disruption were derived from
other better investigated, critically ill populations [27, 28].
Recently, as assumed by Wheatley et al. in a mouse model,
among predisposing factors advanced age elicits a more severe
degree of gut microbial dysbiosis following cutaneous burn
injury than is manifest in younger mice [23]. Clinical studies
demonstrate that advanced age causes a significant increase
in mortality following burn, but the role of the gut in this
age-dependent susceptibility had not yet been investigated
[23]. Furthermore, He et al. [24] reviewed the published
data on intestinal barrier dysfunction in severe burn injury,
focusing on extremely complex mechanisms that involve
numerous signalling molecules and their related pathways.
Besides heat damage, the authors explored different patho-
physiological processes, such as stress, shock, ischaemia/hy-
poxia, inflammation, infection and surgical operation, in the
early and late post-burn period [24]. The results open a
new scenario for the targeted treatment of post-burn intesti-
nal barrier dysfunction, which is theoretically multifacto-
rial and involves multiple, extremely complex pathogenetic
factors such as signalling molecules and related pathways,
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Figure 2. Literature narrative review flowchart
thereby requiring a tailored approach in the future [24].
Some authors [29–32] have explored the gastrointestinal
microbiome during the early stages of burn injury. Their
studies described an increase in gut dysbiosis that suggested
a decrease in some probiotic microbes, such as butyrate-
producing bacteria, while some potentially pathogenic bac-
teria flourished. These authors reported an abundance of
Proteobacteria, flanked mostly by an increase in Escherichia
spp. and Shigella spp. and a decrease in the Firmicutes/Bac-
teroidetes levels in early post-burn stage [29–32] (Figure 1).
Lactobacillus spp., like other lactic acid bacteria (i.e. Bacil-
lales, Sporolactobacillus), have been associated with the pro-
duction of short-chain fatty acids (SCFAs; i.e. acetate, propi-
onate, butyrate, isobutyrate and isovalerate), which are the
primary energy substrates for colonocytes [33] and may help
regulate epithelial barrier function, mucosal immune systems
and inflammatory responses [34, 35]. Moreover, the luminal
content of SCFAs significantly decreases after a severe burn,
suggesting loss of epithelial integrity and immune homeosta-
sis [34, 35]. Although the mechanisms underlying the decrease
in SCFA contents have not yet been precisely defined, data
suggest that a decrease in Firmicutes/Proteobacteria levels
leads to an increase in SCFA contents [34, 35].
Zhang et al., have investigated in a mouse model the role
of Clostridium butyricum (C. butyricum) and its production
of butyrate in burn injury [36]. C. butyricum and butyrate
are beneficial for the homeostasis of intestinal microflora,
and both decrease during burn injury and their levels were
negatively correlated with gut permeability [36]: in conclud-
ing, authors have described that oral administration of C.
butyricum significantly alleviated intestinal permeability.
Dynamic changes in gut bacteria biodiversity were
reported in five patients with severe burn [37]. In the four
survivors, after an initial decrease of probiotic microbes, an
increase in mostly obligate anaerobes and Bifidobacterium
was displayed compared with the non-survivor. Furthermore,
the relative abundance of potentially pathogenic bacteria
(i.e. Pseudomonas and Candida spp.) was higher in the non-
survivor patient [37]. Similarly, Wang et al. investigated the
dynamic changes of the gut microbiome 6 weeks after a severe
burn and explored its association with enteral nutrition (EN)
[38]. After detecting gut dysbiosis, this condition gradually
resolved and EN was associated with the rapid promotion of
gut homeostasis in patients that tolerated EN well. Shimuzu
et al. [37], as supported by Wang et al. [38], highlighted the
usefulness of understanding gut flora and its dynamics to
establish, albeit not directly, prognosis in severe burns.
Interestingly supportive care, such as EN, and its role in
the microbiota are studied as part of burn-related research.
Moreover, the swine model of McIntyre et al. described the
role of fluid resuscitation on gut microbiome [39]. High fluid
resuscitation seems to have the ability to reverse the rise of
potentially pathogenic organisms such as Proteobacteria and
ease the growth of beneficial bacteria such as Bacteroides in
this preliminary study [39].
Lung microbiota in burns
Inhalation injury is present in ∼10–20% of all burn trau-
mas [40]. It predisposes the patient to secondary pneumonia
and acute respiratory distress syndrome and often requires
mechanical ventilation [41]. Currently, very little is known
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about airway microbiota after burn and inhalation injury
[42].
A recent publication by Walsh et al. [43] evaluated lung
microbiome composition in 48 burn patients with inhalation
injury who developed early hypoxaemia compared with
patients without hypoxaemia [44]. The authors described
that hypoxaemic patients had an enrichment of facultative
anaerobes such as Streptococcaceae, Enterobacteriaceae and
Staphylococcaceae (32%, 27% and 83%, respectively) in
comparison to aerobes and strict anaerobes [43]. Hypoxic
conditions may also favour Prevotella melaninogenica
(P. melaninogenica) enrichment, which is part of the healthy
microbiota [45–46]. However, several studies indicate that
P. melaninogenica could also play a non-beneficial role
under certain conditions, as demonstrated in intubated
cystic fibrosis patients [47]. Although the results cannot be
unambiguously interpreted due to the low number of patients
analysed and the possibility of nosocomial acquisition of
these pathogens at admission, such preliminary findings may
support the need for a longitudinal study to identify the
burden and the relevance of the changes mentioned above
[43, 45] (Figure 2).
Skin microbiota in burns
The cutaneous microbiome provides many niches in which
large populations of microbes are subjected to a myriad of
ecological pressures (i.e. temperature, pH). These communi-
ties are directly related to the ability to maintain skin bar-
rier function and encourage inflammation, homeostasis and
wound scarring [48–50]. Shortly after burn injury, the skin
undergoes an excessive activation of the cutaneous and sys-
temic immune responses, targeting commensal and invading
pathogens alike [51]. Specific resident commensal microbes,
mostly in the phyla Actinobacteria (i.e. Proprionibacterium
spp.) and Firmicutes (i.e. Staphylococcus spp.), may boost
skin homeostasis. A recent study observed that a lower abun-
dance of Proprionibacterium spp. is correlated with a higher
risk of pneumonia and wound infections [52–54].
Furthermore, Plichta et al. reported an enrichment in
thermophilic and halophilic bacteria such as Aeribacillus,
Halomonas, Caldalkalibacillus and Nesterenkonia [51]. The
latter are typically isolated from soil and water samples
[55–57] and a direct correlation between these taxa and
the development of pneumonia in the burn population has
been established. Thus far, it is unclear if the enrichment
of these taxa could be partially due to the exposure of the
patient to water sources outside of the hospital setting, such
as during debridement with tap water. Regardless, this could
be a promising microbiome-based morbidity index that may
help stratify patients at admission according to their specific
colonizing microbiome.
A small Asian study [58] evaluated the skin microbiome of
recently healed burn wounds, i.e. 3 months after the incident,
which comprises the late phase of recovery from a burn
injury. Comparative microbiome analysis did not detect any
considerable fluctuations in microbial abundance or compo-
sition when comparing samples from the wound scars and
the unaffected skin of these burn patients [58]. Likewise, they
did not find any compelling temporal dynamics in microbial
abundance or diversification in the burn samples. Curiously,
contrary to early reports on the antibiotic-treated gut micro-
biome, when the skin microbiome was exposed to antibiotic
pressure, it showed an increase in bacterial diversity and
uniformity when compared with the control subjects [58–61].
However, the samples from the burn patients harboured more
Firmicutes than those from the control patients (Figure 1).
There is a consensus that the microbial composition of
skin wounds impacts wound healing, but conclusions are
conflicting [62]. Delayed wound healing in mice was sup-
posed due to dynamic changes and dysbiosis in the micro-
biome and to the effect of oral antimicrobials [63], while
other authors assumed an enhanced wound-healing in the
absence of commensal skin microbiota [64]. Furthermore,
Sanjar et al. have described skin microbiome changes over
11 days following thermal injury [61] with reduced bacterial
richness, altered bacterial genes and associated predicted
functions within bacterial communities [61]. In an in vivo
study, Liu et al. have confirmed a lower community rich-
ness with dysbiosis in burn scars that persist after healing,
despite that these changes and their impact on the rate of
wound healing were not explored [58]. In conclusion, there
remains a considerable knowledge gap in understanding con-
nections between the microbiome and wound healing in burn
injuries [61, 62].
Current & future perspective
In recent years, an increased incidence of infections caused
by MDR bacteria has been reported in several burn centres
[11, 12, 16, 17, 63]. MDR infections lead to a progressive
reduction of therapeutic options and a potential delay in
obtaining appropriate antibiotic therapy, which is usually
associated with increased mortality. [11, 12, 16, 17, 63]. This
overuse and misuse of antibiotics is accompanied by a broad
spectrum of changes involving burn-injured subjects, includ-
ing the resident microbiome at different sites [15, 18–22].
Burn injury itself leads to a disruption of the intestinal barrier,
leading to increased intestinal permeability and translocation
of bacteria or endotoxins [23–25]. Gut dysbiosis, decrease
of probiotics and alteration in the relative abundance of
potentially pathogenetic bacteria may appear from the early
to the late stages after burn injury [23–25]. Theoretically,
the gut may become an entrance for pathogenetic strains,
leading to burn-related sepsis, which is often due to colonizing
MDR bacteria. Some authors [29–32] interestingly reported,
during the early stage of burn injury, a gut increase of gram-
negative bacteria, notably Escherichia spp. and Shigella spp.,
well-known agents of bloodstream infections in burn units
[64, 65]. Gut dysbiosis seems to be strictly related to C.
butyricum viability and its product butyrate, and their levels
were negatively correlated with gut permeability [36]. More-
over, intestinal barrier dysfunction more exactly derives from
a multifactorial complex in which other factors should be
considered for a holistic, therapeutic approach, as assumed by
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He et al. [24]. Recently, a particular focus on the role of sup-
portive care (e.g. EN, probiotics, fluid resuscitation, antimi-
crobial therapies) and their link with dynamic microbiota
changes have enabled us to discover gut bacteria biodiversity
in severe burn patients: probiotics supplementation [36], high
fluid resuscitation [39] and prompt enteral nutrition [37, 38]
may be beneficial for gut homeostasis in hospitalized patients.
On the lung microbiome side, very little is currently known
about airway microbiota after burn and inhalation injury.
Despite that, an episodic enrichment of facultative anaerobes
(notably Staphylococcaceae) in hypoxaemic-scalded subjects
has been observed [43, 45, 46]: preliminary data need to be
validated in a longitudinal study but could open important
perspectives also in antimicrobial stewardship programmes
within burn units [66, 67]. The composition of skin micro-
biota could be a promising precocious index that may help
stratify patients at admission according to their specific col-
onizing microbiome based on the increase in correlation
between the decrease (e.g. Proprionibacterium spp.) or the
abundance (e.g. thermophilic and halophilic bacteria) of some
species and the increased risk of pneumonia or wound infec-
tions [51, 55–57]. Interestingly, reduced bacterial richness
and dysbiosis seems to persist after healing, as assumed by
Liu et al. [58], and thermal injury alters even the functional
level of bacterial communities. The effects of burn injury
on skin microbiome have not been fully elucidated [61, 62,
68, 69]. Furthermore, it is still unclear how the microbiome
composition may interfere with wound healing, but it cer-
tainly appears that there is a deep bond between the two that
requires to be studied further [61, 62, 68, 69].
Conclusions
Fluctuation of the human microbiota is directly linked to
health issues and medical conditions. There are plenty of
approaches to balance the composition of the microbiota.
Therefore, targeting the microbiota has been suggested as an
advanced method to confront different medical conditions.
Some basic questions still need to be answered to fully under-
stand the microbiota complexities from a therapeutic perspec-
tive, particularly in burn patients. Further characterization
of the mechanisms by which stress-induced molecules influ-
ence microbial proliferation and metabolism is necessary to
identify the changes in the microbial phenotypes that directly
influence the host’s innate immune responses required for
optimal healing. Knowledge of the microbiome and its func-
tions may help individualize medicine in the preventive or
curative setting. Targeting or rehabilitating the microbiome
may be an efficient therapeutic strategy in the near future.
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